Co-Diagnostics Ownership | Who Owns Co-Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Co-Diagnostics Ownership Summary


Co-Diagnostics is owned by 18.76% institutional investors, 6.70% insiders, and 74.54% retail investors. Vanguard group is the largest institutional shareholder, holding 5.83% of CODX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.01% of its assets in Co-Diagnostics shares.

CODX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCo-Diagnostics18.76%6.70%74.54%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryMedical Device Stocks40.18%9.93%49.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.78M5.83%$1.33M
Private advisory group1.18M3.87%$886.23K
Renaissance555.62K1.82%$416.72K
Blackrock502.02K1.68%$627.53K
Blackrock funding, inc. /de504.24K1.65%$378.18K
Geode capital management345.51K1.13%$259.21K
Bridgeway capital management272.90K0.89%$204.68K
Susquehanna group, llp259.13K0.85%$194.34K
Bank of new york mellon137.07K0.45%$102.80K
Kestra advisory services122.81K0.40%$92.11K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Private advisory group1.18M0.10%$886.23K
Thompson davis57.20K0.03%$42.75K
Smi advisory services28.00K0.00%$21.34K
Bridgeway capital management272.90K0.00%$204.68K
Koss-olinger consulting58.10K0.00%$44.00K
Physician wealth advisors28.38K0.00%$21.28K
Two sigma securities16.46K0.00%$12.35K
Renaissance555.62K0.00%$416.72K
Kestra advisory services122.81K0.00%$92.11K
Tower research capital llc (trc)6.23K0.00%$4.67K

Top Buyers

HolderShares% AssetsChange
Private advisory group1.18M0.10%1.18M
Susquehanna group, llp259.13K-71.56K
Squarepoint ops28.36K-28.36K
Geode capital management345.51K-24.24K
Simplex trading27.52K-16.78K

Top Sellers

HolderShares% AssetsChange
D. e. shaw---46.30K
Xtx topco---23.63K
Townsquare capital---20.00K
Peak6 investments---19.80K
Citadel advisors3.30K--19.60K

New Positions

HolderShares% AssetsChangeValue
Private advisory group1.18M0.10%1.18M$886.23K
Squarepoint ops28.36K-28.36K$21.27K
Goldman sachs group15.99K-15.99K$11.99K
Fmr218.00-218.00$164.00

Sold Out

HolderChange
Qube research-13.00
Financial network wealth advisors-100.00
Northwestern mutual wealth management-100.00
National bank of canada /fi/-200.00
Capital performance advisors llp-4.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024437.50%5,722,18629.65%188.96%1566.67%9-18.18%
Sep 30, 202439-15.22%4,402,641-5.17%145.97%9-57.14%1042.86%
Jun 30, 20244612.20%4,642,6216.47%157.05%21133.33%7-41.67%
Mar 31, 202441-16.33%4,360,457-6.96%145.83%9-35.71%12-14.29%
Dec 31, 2023494.26%4,686,6142.81%156.50%147.69%1440.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.28M4.01%-
Vanguard Total Stock Mkt Idx Inv1.28M4.00%-
Vanguard Institutional Extnd Mkt Idx Tr444.78K1.39%-
Bridgeway Ultra-Small Company272.90K0.85%-
Fidelity Extended Market Index165.97K0.52%-1.06K
BlackRock Extended Equity Market K72.43K0.23%-31.00
Extended Equity Market Fund K71.67K0.22%220.00
iShares Micro-Cap ETF69.29K0.22%-
Fidelity Total Market Index53.05K0.17%-
Spartan Total Market Index Pool E43.70K0.14%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 20, 2023Brown Brian Lee Chief Financial OfficerBuy$5.70K
Sep 08, 2021Durenard Eugene-Sell$20.91K
May 19, 2021BENSON REED L General CounselSell$830.39K
May 19, 2021BENSON REED L General CounselSell$8.53
May 19, 2021BENSON REED L General CounselSell$93.23K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2023 Q4--
2023 Q2--
2023 Q11-

CODX Ownership FAQ


Who Owns Co-Diagnostics?

Co-Diagnostics shareholders are primarily institutional investors at 18.76%, followed by 6.70% insiders and 74.54% retail investors. The average institutional ownership in Co-Diagnostics's industry, Medical Device Stocks, is 40.18%, which Co-Diagnostics falls below.

Who owns the most shares of Co-Diagnostics?

Co-Diagnostics’s largest shareholders are Vanguard group (1.78M shares, 5.83%), Private advisory group (1.18M shares, 3.87%), and Renaissance (555.62K shares, 1.82%). Together, they hold 11.53% of Co-Diagnostics’s total shares outstanding.

Does Blackrock own Co-Diagnostics?

Yes, BlackRock owns 1.68% of Co-Diagnostics, totaling 502.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 627.53K$. In the last quarter, BlackRock increased its holdings by 1.98K shares, a 0.40% change.

Who is Co-Diagnostics’s biggest shareholder by percentage of total assets invested?

Private advisory group is Co-Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 1.18M Co-Diagnostics shares, valued at 886.22K$.

Who is the top mutual fund holder of Co-Diagnostics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Co-Diagnostics shares, with 4.01% of its total shares outstanding invested in 1.28M Co-Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools